HgCapital Trust Plc
HgCapital Trust Plc is an investment trust company which primarily invests in technology and technology-enabled services including media and telecommunication (TMT) companies across Europe with the objective of providing shareholders long term capital gains in excess of the FTSE All-share index by investing in unquoted companies.
HGT Financial Performance (Interim results for six months ended 30 June 2019)
On 9th September 2019, the company announced its interim financial results where it reported a strong NAV performance. The NAV as on 30 June 2019 per share stood at GBP 2.42 with an absolute Net Asset Value (NAV) at £975.1 million. The share price stood at GBP 2.16 per share as on 30th June 2019. The company also reported robust revenue growth of 26 per cent and EBITDA growth of 35 per cent in the trailing twelve months across the top 20 investments, which makes up for 88 per cent of the total portfolio. The share price performance of these top 20 investments in the market was excellent with an EV/EBITDA multiple of 19.5x and a Net Debt to EBITDA ratio of 6.3x. The board’s primary objective has been on improving liquid performance of the stocks, and hence there was a share split of ten to one share in the month of May 2019. The company has stayed on track with its investment objectives by outperforming the FTSE All-Share Index over one, three, five, ten- and twenty-year periods.
The company added a few new investments in its portfolio within the reported investment cycle, which include Transporeon group, which is one of the global leaders in cloud-based supply chain platform providers, team.blue, a European giant in large platform hosting provisions for SMEs. The company has also reported that there has been a continued M&A activity across the portfolio, which is a major investment strategy, with one of its investments, foundry being sold to Roper technologies delivering a 22 per cent gross IRR over the investment period.
PureTech Health Plc
PureTech Health Plc is a multi-disciplinary healthcare company. The company has 2 segments – growth stage business and project phase business. The growth stage business involves businesses whose focus is on development of products that solve healthcare problems in varied markets and project phase business involves businesses that focus on financing, sourcing and creating new product categories and newly created businesses whose technologies and processes are in the process of evaluation.
PRTC Financial Performance (six months ended 30th June 2019)
In line with the forecasted expectations, the company has continued investing in affiliate as well as internal pipeline research and it continues to invest in infrastructure to support the commercial launch of Gelesis 100 for the treatment of obesity after it was approved by the FDA in April 2019. The company raised $322.8 million in capital, out of which Karuna, through an initial public offering, raised $102.6 million in gross proceeds. The company reported the group level cash reserves of $202.1 million as on 30th June 2019. The company has also reported a revenue of $4.4 million in the H1 2019, the year mainly driven by company’s various License Agreements with its partners. The operating loss reported was at $70.3 million up by 34.3 per cent year on year. The biggest factor behind this was the increased spending in R & D and also the investment in pre-launch expenses ahead of the commercial launch of Gelesis 100. All these activities drove the total loss for the period to $14.0 million.
PRTC Stock Performance
On 11th September 2019, at 8:45 AM GMT, while writing, PRTC shares were trading at GBX 276.00 per share; flat as compared to the previous day’s closing price. As of last trade, PureTech Healthcare Plc stock traded 10.10 per cent below its 52-week high of 307, set on August 13, 2019 and 44.92 per cent or GBX 124 per share above its 52-week low price of GBX 152, set on September 11, 2018. The Market Capitalisation (M-Cap) of the company was around GBP 780.01 million.
2,470 shares of the company have been traded. Average volume traded has been 80,050. The stock has surged 73.86 per cent in the last one year from the price of GBX 157.91 per share.
The beta of the stock was recorded at 0.8510, indicating that it is less volatile in its movement in comparison to the benchmark index.
Equiniti Group Plc
The company provides financial services using its technological platforms to a varying range of organisations spread across diverse sectors of the world. The company’s various business divisions are; Investment solutions (Financial Services), Intelligent Solutions (Knowledge Services), Pension Solutions and Interest (Financial Services). These Solutions offer an array of products and platform- based services, including share filing for 50 per cent of the London Stock Exchange (FTSE 100), and the management of save as you earn schemes and other share incentive public schemes. It also provides share trading and dealing, portfolio management services and an array of services which include the provision of international payments to commercial clients and their employees, as well as end to end payment solutions for direct to retail customers. The company serves BFSI, Tech, Media & Telecommunication, Health, Public Services and Retail industries through its services.
EQN Financial Performance (Interim results for six months ended 30th June 2019)
The company reported its interim results for the first half of 2019 on 2nd August 2019. The company’s revenue stood at £275.1 million, posting a year on year surge of 8.3 per cent from H1 2018 revenue of £254.0 million. Investment Solutions delivered strong revenue growth at £73.1 million driven by the High Net Worth Client base and increasing market share while Intelligent Solutions also delivered strong growth with remediation services and software sales in credit services being the particular drivers of growth. The underlying EBITDA prior to non-operating charges of £5.5million showed a growth of 3.9 per cent at £60.9 million from H1 2018 Underlying EBITDA at £58.6 million showing strong growth in every division. All these factors contributed to a major increase Year on year in Profit After Tax (PAT) of about 257.7 per cent at £9.3 million from £2.6 million in H1 2018. On the back of the sturdy performance, the board has declared an interim dividend of GBX 1.95 per share in line with the company’s progressive dividend policy.
EQN Stock Performance
On 11th September 2019, at 9:30 AM GMT, while writing, EQN shares were trading at GBX 211.20 per share; up by 1.25 per cent or GBX 2.60 per share as compared to the previous day’s closing price of GBX 208.6 per share. As of last trade Equiniti Group Plc stock traded 26.43 per cent above its 52-week low of 167.05, set on March 12, 2019 and 26.4 per cent or GBX 55.8 per share below its 52-week high price of GBX 267, set on October 1, 2018. The Market Capitalisation (M-Cap) of the company was around GBP 760.42 million.
39,060 shares of the company have been traded till the time of writing on 11 September 2019. Average volume traded has been 325,070. The stock has plunged 17.50 per cent in the last one year from the price of GBX 256 per share.
The beta of the stock was recorded at 0.0951, indicating that it is very less volatile in its movement in comparison to the benchmark index.
Domino’s Pizza Group Plc
Domino’s Pizza Group Plc is a United Kingdom based global Pizza delivery company. In addition, the company has a controlling stake in the Domino’s brand agreements across Europe as well as controlling stake in various European cities. The company’s main operations are held out of Milton Keynes, near West Ashland along with some satellite bases in Bristol and Livingston.
DOM Stock Performance
On 11th September 2019, at 9:50 AM GMT, while writing, DOM shares were trading at GBX 253.86 per share; up by 2.65 per cent or GBX 6.56 per share as compared to the previous day’s closing price at GBX 247.30 per share. As of last trade, Domino’s Pizza Group Plc stock traded 15.97 per cent above its 52-week low of 218.90, set on August 19, 2019, and 18.58 per cent or GBX 47.19 per share below its 52-week high price of GBX 301.05, set on November 9, 2018. The Market Capitalisation (M-Cap) of the company was around GBP 1143.09 million.
237,360 shares of the company have been traded till the time of writing on 11 September 2019. Average volume traded has been 929,160. The stock has plunged 11.02 per cent in the last one year from the price of GBX 285.30 per share.
The beta of the stock was recorded at 1.2437, indicating that it is more volatile in its movement in comparison to the benchmark index.